333 related articles for article (PubMed ID: 30948820)
1. Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials.
Mishima E; Haruna Y; Arima H
Hypertens Res; 2019 Apr; 42(4):469-482. PubMed ID: 30948820
[TBL] [Abstract][Full Text] [Related]
2. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
3. First-line renin-angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus.
Wang G; Chen Y; Li L; Tang W; Wright JM
J Hum Hypertens; 2018 Jul; 32(7):494-506. PubMed ID: 29713053
[TBL] [Abstract][Full Text] [Related]
4. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
[TBL] [Abstract][Full Text] [Related]
5. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H
Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
[TBL] [Abstract][Full Text] [Related]
6. The effects of renin-angiotensin system inhibitors on mortality, cardiovascular events, and renal events in hypertensive patients with diabetes: a systematic review and meta-analysis of randomized controlled trials.
Kunimura A; Himuro N; Fujiyoshi A; Segawa H; Ohnishi H; Saitoh S
Hypertens Res; 2019 May; 42(5):669-680. PubMed ID: 30948835
[TBL] [Abstract][Full Text] [Related]
7. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
8. Renin-Angiotensin System Blockade and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Meta-analysis of Randomized Controlled Trials.
Hiremath S; Fergusson DA; Fergusson N; Bennett A; Knoll GA
Am J Kidney Dis; 2017 Jan; 69(1):78-86. PubMed ID: 27712852
[TBL] [Abstract][Full Text] [Related]
9. Renal protection in hypertensive patients: selection of antihypertensive therapy.
Wenzel RR
Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive agents for preventing diabetic kidney disease.
Lv J; Perkovic V; Foote CV; Craig ME; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2012 Dec; 12():CD004136. PubMed ID: 23235603
[TBL] [Abstract][Full Text] [Related]
11. Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis.
Vejakama P; Thakkinstian A; Lertrattananon D; Ingsathit A; Ngarmukos C; Attia J
Diabetologia; 2012 Mar; 55(3):566-78. PubMed ID: 22189484
[TBL] [Abstract][Full Text] [Related]
12. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
13. Effect of renin-angiotensin system inhibitors on survival in kidney transplant recipients: A systematic review and meta-analysis.
Jiang YM; Song TR; Qiu Y; Liu JP; Wang XD; Huang ZL; Lin T
Kaohsiung J Med Sci; 2018 Jan; 34(1):1-13. PubMed ID: 29310811
[TBL] [Abstract][Full Text] [Related]
14. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
Zhao HJ; Li Y; Liu SM; Sun XG; Li M; Hao Y; Cui LQ; Wang AH
Ren Fail; 2016 Jul; 38(6):849-56. PubMed ID: 27055479
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin-aldosterone system blockers effect in chronic kidney disease progression in hypertensive elderly patients without proteinuria: PROERCAN trial.
García-Prieto AM; Verdalles Ú; de José AP; Arroyo D; Aragoncillo I; Barbieri D; Camacho RE; Goicoechea M
Hipertens Riesgo Vasc; 2024; 41(2):95-103. PubMed ID: 38508877
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: a systematic review and meta-analysis.
Daien V; Duny Y; Ribstein J; du Cailar G; Mimran A; Villain M; Daures JP; Fesler P
Am J Hypertens; 2012 Jan; 25(1):126-32. PubMed ID: 21993366
[TBL] [Abstract][Full Text] [Related]
17. The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic kidney disease.
Weir MR
Postgrad Med; 2009 Jan; 121(1):96-103. PubMed ID: 19179817
[TBL] [Abstract][Full Text] [Related]
18. The effect of renin-angiotensin-aldosterone system blockers on the progression of chronic kidney disease in hypertensive elderly patients without proteinuria: PROERCAN study. Rationale and design.
García-Prieto AM; Verdalles Ú; de José AP; Verde E; Arroyo D; Aragoncillo I; Linares T; Barbieri D; Goicoechea M
Hipertens Riesgo Vasc; 2020; 37(3):101-107. PubMed ID: 32156479
[TBL] [Abstract][Full Text] [Related]
19. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis.
Wang B; Wang F; Zhang Y; Zhao SH; Zhao WJ; Yan SL; Wang YG
Lancet Diabetes Endocrinol; 2015 Apr; 3(4):263-74. PubMed ID: 25660574
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.
Kunz R; Friedrich C; Wolbers M; Mann JF
Ann Intern Med; 2008 Jan; 148(1):30-48. PubMed ID: 17984482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
